Category: Layoffs
-
Tempest lays off 81% of staff as it ponders strategic alternatives
Despite partnering with Roche for its lead oncology candidate, the cash strapped company reported having $30.3 million in cash reserves at the end of last year.
-
Third Harmonic shares soar after liquidation and asset sale plans
The Board of Directors has authorized liquidation and plans to request stockholder approval for dissolution during the annual shareholder meeting in June.
-
Allakos stock nosedives after CSU candidate fails Phase I trial
Allakos also plans to lay off 75% of its employees, explore strategic alternatives, and discontinue the development of Phase I chronic spontaneous urticarial therapy.
-
Atara axes half of its staff following FDA rejection and clinical hold
The workforce reduction follows the US FDA’s clinical hold on the company’s T-cell therapies, including Ebvallo.
Latest posts
-
Navigating the Risks and Rewards of Biomarker-Based Surrogates and Accelerated Approval
The risks and rewards of biomarker-based surrogates are crucial for optimizing clinical trial outcomes and guiding effective treatments.
-
ASH25: Gallop’s LYT-200 shows unprecedented survival in AML
The company’s execs talk about the striking efficacy and safety signals seen in Phase I data, the science behind the molecule, and their vision for transforming AML therapy.
-
Promis reports first human evidence of aβ oligomer reduction by pmn310
PMN310 demonstrates dose-dependent reduction of amyloid-beta oligomers in human CSF, marking a key milestone in Alzheimer’s treatment development.
-
Urologic Health secures $11 million for non-invasive bladder monitoring
Urologic Health raises $11million seed funding to advance a catheter-free bladder monitoring platform toward FDA clearance and US market entry.
-
Novo Nordisk’s denecimig cuts bleeding in hemophilia A regardless of inhibitors
Phase III trial shows once‑monthly and once‑weekly denecimig (Mim8) significantly reduces annualized bleeding rate versus standard care, with up to 95% of patients bleed‑free.